Integrated Biopharma Revenue, Growth & Competitor Profile

DBA INTEGRATED BIOPHAR

Company Profile & Annual Report for Integrated Biopharma

Access the complete profile.

Integrated Biopharma Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325 Chemical Manufacturing
Additional NAICS Codes	424 Merchant Wholesalers, Nondurable Goods
Address	225 Long Avenue Hillside, NJ 07205

Note: Revenues for privately held companies are statistical evaluations.


Integrated Biopharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Integrated Biopharma's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Integrated Biopharma is classified as operating in the Chemical Manufacturing industry, NAICS Code 325.

Integrated Biopharma Annual Revenue and Growth Rate

Integrated Biopharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Integrated Biopharma's revenues are gauged from an analysis of company filings.

Integrated Biopharma's Income Statement (based on Industry Averages)

Integrated Biopharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Integrated Biopharma is developing and marketing. Integrated Biopharma doesn't have any recent trademark applications, indicating Integrated Biopharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CACTUSLIM dietary supplements	01/21/2005
CACTUS SLIM dietary supplements	01/21/2005

See all trademarks and details in the Full Report.

Market Share of Integrated Biopharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Integrated Biopharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PROCTER & GAMBLE COMMERCIAL	Cincinnati, OH	100
DOW CHEMICAL	Midland, MI	89
PFIZER	New York, NY	74
ABBOTT LABORATORIES	Abbott Park, IL	57
BRISTOL-MYERS SQUIBB	Lawrenceville, NJ	57
COLGATE-PALMOLIVE	New York, NY	47
ELI LILLY	Indianapolis, IN	43
MERCK SHARP & DOHME	Rahway, NJ	41
CSL BEHRING	King Of Prussia, PA	40

Nearby Competitors

These companies are similar in business line and location to Integrated Biopharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BEAUTY-FILL	Hillside, NJ	100
INTEGRATED BIOPHARMA	Hillside, NJ	30
VITA-PURE	Roselle, NJ	15

Future Competition: Integrated Biopharma's Fastest Growing Competitors

These companies are in the same general field as Integrated Biopharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)